Literature DB >> 25589418

Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.

Erkan Alpsoy1, Ayse Akman-Karakas, Soner Uzun.   

Abstract

Autoimmune bullous diseases are rare, organ-specific, a group of blistering disease of skin and mucous membranes. Recent studies suggest that the frequency of the autoimmune bullous diseases has been increasing. Pemphigus vulgaris and bullous pemphigoid are the most frequently reported autoimmune bullous diseases. High incidence of autoimmune bullous diseases in some ethnic groups such as pemphigus in Ashkenazi Jewish, or in some regions such as pemphigus foliaceus in Brazil has been shown to be related to genetic and environmental factors, respectively. Pemphigus has been reported more frequently in the female gender. Although it is most frequently diagnosed between the ages 50 and 60 in European countries, in the remaining countries in the world, it is seen between the ages of 30 and 50. Bullous pemphigoid is generally seen above 70 years of age. Although overall incidence is slightly higher in females, after the age of 80 years it is more frequent in males. Both pemphigus vulgaris and bullous pemphigoid has a chronic course with recurrences. Mortality risk of the patients with bullous pemphigoid was found at least 2 times higher and the mortality risk of the patients with pemphigus was found approximately 3 times higher than that of the general population. In this review, the results obtained from the epidemiological studies were analyzed according to geographic regions, and especially epidemiologic features of two prevalent autoimmune bullous diseases, pemphigus and bullous pemphigoid have been discussed.

Entities:  

Mesh:

Year:  2015        PMID: 25589418     DOI: 10.1007/s00403-014-1531-1

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  35 in total

Review 1.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

Review 2.  [Pemphigoid diseases. Autoimmune diseases in the elderly].

Authors:  O N Horváth; J Jankásková; A Walker; M Sárdy
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

Review 3.  The Immunogenetics of Autoimmune Blistering Diseases.

Authors:  Diana Kneiber; Eric H Kowalski; Kyle T Amber
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  Immune response in pemphigus and beyond: progresses and emerging concepts.

Authors:  Giovanni Di Zenzo; Kyle T Amber; Beyza S Sayar; Eliane J Müller; Luca Borradori
Journal:  Semin Immunopathol       Date:  2015-11-23       Impact factor: 9.623

5.  Spatial Distribution of Pemphigus Occurrence over Five Decades in Southeastern Brazil.

Authors:  Beatriz Smidt Celere; Sebastian Vernal; Leonardo La Serra; Maria José Franco Brochado; Luiz Eduardo Moschini; Ana Maria Roselino; Susana Inés Segura-Muñoz
Journal:  Am J Trop Med Hyg       Date:  2017-09-21       Impact factor: 2.345

6.  Expression of human endogenous retroviruses in pemphigus vulgaris patients.

Authors:  Abbas Karimi; Nafiseh Esmaili; Mohammadreza Ranjkesh; Mohammad Ali Zolfaghari
Journal:  Mol Biol Rep       Date:  2019-08-31       Impact factor: 2.316

7.  Psychiatric and neurological disorders are associated with bullous pemphigoid - a nationwide Finnish Care Register study.

Authors:  Anna-Kaisa Försti; Jari Jokelainen; Hanna Ansakorpi; Allan Seppänen; Kari Majamaa; Markku Timonen; Kaisa Tasanen
Journal:  Sci Rep       Date:  2016-11-15       Impact factor: 4.379

8.  Nail Involvement during Pemphigus.

Authors:  Bouchra Baghad; Soumiya Chiheb
Journal:  Skin Appendage Disord       Date:  2019-08-27

9.  Increased Risk of Squamous Cell Carcinoma of the Skin and Lymphoma Among 5,739 Patients with Bullous Pemphigoid: A Swedish Nationwide Cohort Study.

Authors:  Zeyad Albadri; Kristofer Thorslund; Henrike Häbel; Oliver Seifert; Carina Grönhagen
Journal:  Acta Derm Venereol       Date:  2020-10-14       Impact factor: 3.875

10.  Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats.

Authors:  Boaz Arzi; Emily Mills-Ko; Frank J M Verstraete; Amir Kol; Naomi J Walker; Megan R Badgley; Nasim Fazel; William J Murphy; Natalia Vapniarsky; Dori L Borjesson
Journal:  Stem Cells Transl Med       Date:  2015-11-18       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.